APA (7th ed.) Citation

Panos Kefalas, Omar Ali, Jesper Jørgensen, Nick Merryfield, Tim Richardson, Adam Meads, . . . Matthew Durdy. (2018). Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Panos Kefalas, Omar Ali, Jesper Jørgensen, Nick Merryfield, Tim Richardson, Adam Meads, Laura Mungapen, and Matthew Durdy. Establishing the Cost of Implementing a Performance-based, Managed Entry Agreement for a Hypothetical CAR T-cell Therapy. Taylor & Francis Group, 2018.

MLA (9th ed.) Citation

Panos Kefalas, et al. Establishing the Cost of Implementing a Performance-based, Managed Entry Agreement for a Hypothetical CAR T-cell Therapy. Taylor & Francis Group, 2018.